Subject: Fenofibrate Research Study                                  

Hi all;

I recently got some info about a research study starting here on
Toronto that I thought might be of interest. The following is a brief
summary of their handout requesting volunteers. (Any errors or
misinterpretations are mine).

        Diabetes Atherosclerosis Intervention Study

Dabetics are 2 to 4 times as likely to develop coronary artery disease
than non-diabetics. Coronary atherosclerosis, the narrowing of the
arteries around the heart, is linked to increased blood cholesterol
and diabetes. Research in non-diabetics has shown that lowering
cholesterol levels is good, and can both slow the deterioration and
also unblock vessels, thus decreasing the risk of heart attack.

This is a double-blind 3-5 year study, involving 360 Type II diabetics
from 6 cities (3 in Canada, 3 in Scandanavia). The drug fenofibrate
(Lipidil) is effective at lowering cholesterol and is now available in
a new long-lasting (200 mg) format. Males & females, all with
moderately elavated cholesterol & triglyceride levels will be invited
to participate. Angiograms at start and finish, 1/2 the participants
on fenofibrate, rest on a placebo. Dieticians will put everybody on
low fat (>30%) diets, regular blood tests and check-ups.

I will not be able to participate in the study myself, but was curious
if anyone had any thoughts or observations. . . Mike

                                  //// michael.wal…@CANREM.COM ////

 * 1st 2.00b #1853 * May the bluebird of happiness fly up your nose.